Labcorp Holdings Inc. (LH) Stock Forecast
Data as of May 2, 2026Healthcare · Current price $256.56 (-0.10%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Feb 24, 2026 | David Westenberg | Piper Sandler | $300.00 | +16.9% |
| Oct 29, 2025 | Kevin Caliendo | UBS | $320.00 | +24.7% |
| Oct 28, 2025 | Michael Cherny | Leerink Partners | $342.00 | +33.3% |
| Oct 17, 2025 | Ann Hynes | Mizuho Securities | $320.00 | +24.7% |
| Jul 25, 2025 | Kevin Caliendo | UBS | $305.00 | +18.9% |
| Feb 3, 2025 | Luke Sergott | Barclays | $271.00 | +5.6% |
| Sep 24, 2024 | Elizabeth Anderson | Evercore ISI | $240.00 | -6.5% |
| Sep 23, 2024 | Brian Tanquilut | Jefferies | $265.00 | +3.3% |
| Aug 5, 2024 | Michael Ryskin | Bank of America Securities | $260.00 | +1.3% |
| Aug 2, 2024 | Stephanie Davis | Barclays | $249.00 | -2.9% |
| Aug 2, 2024 | Eric Coldwell | Robert W. Baird | $277.00 | +8.0% |
| Mar 25, 2024 | David Toung | Argus Research | $250.00 | -2.6% |
| Feb 11, 2022 | Derik de Bruin | Bank of America Securities | $370.00 | +44.2% |
| Jan 28, 2022 | Pito Chickering | Deutsche Bank | $294.00 | +14.6% |
| Jul 30, 2021 | David S Macdonald | Truist Financial | $350.00 | +36.4% |
| May 20, 2021 | Jasper Hellweg | Argus Research | $295.00 | +15.0% |
Top Analysts Covering LH
LH vs Sector & Market
| Metric | LH | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.17 | 2.24 | 2.41 |
| Analyst Count | 6 | 8 | 18 |
| Target Upside | +21.4% | +1150.2% | +14.9% |
| P/E Ratio | 22.72 | 6.85 | 31.19 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $14.51B | $14.67B | $14.80B | 14 |
| 2027-03-31 | $3.64B | $3.67B | $3.69B | 5 |
| 2027-06-30 | $3.83B | $3.85B | $3.88B | 5 |
| 2027-09-30 | $3.88B | $3.91B | $3.93B | 5 |
| 2027-12-31 | $3.81B | $3.84B | $3.87B | 5 |
| 2028-03-31 | $3.82B | $3.84B | $3.87B | 4 |
| 2028-06-30 | $4.00B | $4.03B | $4.06B | 4 |
| 2028-09-30 | $4.04B | $4.07B | $4.10B | 4 |
| 2028-12-31 | $3.96B | $3.98B | $4.01B | 4 |
| 2029-12-31 | $17.13B | $17.35B | $17.56B | 5 |
| 2030-12-31 | $15.03B | $15.22B | $15.40B | 5 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $16.79 | $17.86 | $18.15 | 12 |
| 2027-03-31 | $4.45 | $4.49 | $4.53 | 4 |
| 2027-06-30 | $5.04 | $5.08 | $5.13 | 5 |
| 2027-09-30 | $4.89 | $4.94 | $4.98 | 8 |
| 2027-12-31 | $4.65 | $4.70 | $4.74 | 4 |
| 2028-03-31 | $4.94 | $4.98 | $5.03 | 5 |
| 2028-06-30 | $5.39 | $5.44 | $5.49 | 7 |
| 2028-09-30 | $5.22 | $5.27 | $5.32 | 10 |
| 2028-12-31 | $4.97 | $5.02 | $5.06 | 5 |
| 2029-12-31 | $22.84 | $23.23 | $23.59 | 4 |
| 2030-12-31 | $23.40 | $23.80 | $24.17 | 2 |
Frequently Asked Questions
What is the analyst consensus for LH?
The consensus among 6 analysts covering Labcorp Holdings Inc. (LH) is Buy with an average price target of $321.33.
What is the highest price target for LH?
The highest price target for LH is $370.00, set by Derik de Bruin at Bank of America Securities on 2022-02-11.
What is the lowest price target for LH?
The lowest price target for LH is $240.00, set by Elizabeth Anderson at Evercore ISI on 2024-09-24.
How many analysts cover LH?
6 analysts have issued ratings for Labcorp Holdings Inc. in the past 12 months.
Is LH a buy or sell right now?
Based on 6 analyst ratings, LH has a consensus rating of Buy (2.17/5) with a +21.4% upside to the consensus target of $321.33.
What are the earnings estimates for LH?
Analysts estimate LH will report EPS of $17.86 for the period ending 2026-12-31, with revenue estimated at $14.67B.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.